HomeTagsSGX

SGX

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
spot_img
SGX-LISTED COMPANIES

Why ISEC Healthcare’s Q1 2026 Profit Dip Isn’t What It Seems

In the world of financial reporting, a double-digit drop in net profit is usually...
SGX-LISTED COMPANIES

Why Abundante’s 11% Revenue Jump Led To A 98% Profit Crash In FY2026

Lessons from Abundante’s FY2026 Results In the world of corporate finance, the relationship between top-line...
SGX-LISTED COMPANIES

ISOTeam Secures S$30.1M In New Contracts As Order Book Grows To S$186.5M

Drones, Dividends, and the Future of Singapore's HDBs: The Surprising Tech Pivot of ISOTeam Scaffolding...
SGX-LISTED COMPANIES

TSH Resources FY2025 – Share Buybacks & A Massive New Dividend Payout

4 Surprising Takeaways from TSH Resources’ 2025 Performance How does a massive plantation group build...
SGX-LISTED COMPANIES

Kin Global’s IPO – Singapore’s Top Sports Firm Is Going Public

The Quiet Powerhouse Behind Singapore’s Global Sporting Revolution If you have ever stood in the...
SGX-LISTED COMPANIES

Is Pan-United’s Stock Rally Over?

Why Pan-United’s 40% Rally Signals a Change in the Investment Guard How does a "boring"...
SGX-LISTED COMPANIES

Why Halcyon Agri’s Losses Tripled In FY2025

4 Surprising Truths from Halcyon Agri’s FY2025 Halcyon Agri’s 2025 financial report presents a brutal...
SGX-LISTED COMPANIES

Why AvePoint Is The Silent Architect Of The AI Revolution

Data Integrity is the Unseen Engine of the AI Revolution As global enterprises race to...
SGX-LISTED COMPANIES

Lum Chang Creations Continues To Grow Ahead Of Its Mainboard Upgrade

5 Surprising Takeaways from Lum Chang Creations’ Record Growth In the high-stakes architectural tapestry of...
SGX-LISTED COMPANIES

Miyoshi Sells Assets To Repay Debt In HY2026

The Paradox of Modern Business Success In the traditional world of business, success is often...
SGX-LISTED COMPANIES

The Reason The US Department Of War Awarded iX Biopharma A $41M Contract For A Painkiller

Beyond the Needle and the Pill The opioid epidemic remains one of the most significant...
SGX-LISTED COMPANIES

How Vietnam Is Negatively Impacting Hyphens Pharma’s Growth

The Southeast Asian Pharmaceutical Puzzle Navigating the healthcare landscape in Southeast Asia is often described...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...